Cellerant Therapeutics Inc., a biotechnology company developing novel hematopoietic stem cell-based cellular and antibody therapies for blood disorders and cancer, announced today that it has dosed its first patient in a Phase 1 IND trial of CLT-008 for hematological malignancies. CLT-008 is an off-the-shelf...
Cellerant Therapeutics Announces Dosing Of First Patient In A Phase 1 Trial Of CLT-008 For Hematological Malignancies
Can Polypectomy Be Performed Without Interruption Of Anticoagulation?
Currently, patients taking anticoagulants to prevent stroke and blood clots are often recommended to stop these medications in order to perform colonoscopy with removal of polyps. However, interruption of these medications can place patients at risk of stroke and blood clots. A group led by Shai Friedland...
Once-Daily Oral Xarelto Significantly More Effective At Reducing Blood Clots Than Twice Daily Subcutaneous, Enoxaparin
Data from the pivotal Phase III RECORD4[1] clinical trial, published online in The Lancet demonstrate that Bayer’s novel anticoagulant Xarelto® (rivaroxaban), taken as one tablet, once-daily, was significantly more effective at reducing the occurrence of venous blood clots following elective total...
Haemophilia Soceity Hopes Lords Debate Will Bring News On The Implementation Of The Archer Report, UK
A debate in the House of Lords today will call attention to the findings of the Archer Independent Public Inquiry into the contaminated blood disaster. Lord Morris of Manchester (Labour), President of the All Party Parliamentary group on Haemophilia, has secured the debate, which will hear from Lord...
Hyperion Therapeutics Announces Results For Phase II Study In Urea Cycle Disorders
Hyperion Therapeutics, Inc. announced top-line results from their phase II study of HPN-100 for the treatment of urea cycle disorders. The data was presented on March 27th at the 16th Annual Clinical Genetics Meeting of the American College of Medical Genetics by Brendan Lee, M.D., Ph.D., Howard Hughes...
The Deciphering Of Blood Stem Cell Attachment, Communication Has Implications For Leukemia Treatment, Artificially Culturing Blood Cells
Researchers at the National Institutes of Health have deciphered a key sequence of events governing whether the stem cells that produce red and white blood cells remain anchored to the bone marrow, or migrate into the circulatory system. An understanding of the factors that govern migration of blood...
OrSense Receives European CE Mark Approval For Continuous Non-Invasive Hemoglobin And Pulse Oximetry Monitoring System
OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, announced today at the 29th http://www.intensive.org/index.asp (ISICEM) in Brussels, Belgium, that it has received a European CE Mark (Conformité Européenne) approval for its NBM-200MP, a multi-parameter...
Family History Associated With Increased Risk Of Blood Clots
Children and siblings of those with venous thrombosis, or blood clots in the veins, appear to have more than double the risk of developing the condition than those without a family history, according to a report in the March 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. Venous...
Mercy Integrated Labs Implements PNA FISH(R) Tests To Help Clinicians Provide Best Care For Patients With Bloodstream Infections
AdvanDx announced that Mercy Integrated Labs in Toledo, Ohio has implemented AdvanDx’s PNA FISH(R) tests to identify bloodstream pathogens 1 to 3 days earlier than conventional methods to help physicians, pharmacists and nurses at hospitals served by the lab to improve care and outcomes for patients...
New Clinical Study Presented At The Society For Critical Care Medicine Shows Value Of Pulse CO-Oximetry(TM) To Identify Acquired Methemoglobinemia
Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, announced that a new study presented at the Society for Critical Care Medicine 38th Critical Care Congress suggests providers should consider routine screening with Masimo Rainbow...